上睑下垂
细胞生物学
单核细胞
炎症体
巨噬细胞
半胱氨酸蛋白酶1
化学
半胱氨酸蛋白酶
细胞凋亡
生物
免疫学
程序性细胞死亡
生物化学
受体
体外
作者
Marian C. Okondo,Darren C. Johnson,Ramya Sridharan,Eun Bin Go,Ashley J. Chui,Mitchell S. Wang,Sarah E. Poplawski,Wenwang Wu,Yuxin Liu,Jack H. Lai,David G. Sanford,Michael O Arciprete,Todd R. Golub,William W. Bachovchin,Daniel A. Bachovchin
标识
DOI:10.1038/nchembio.2229
摘要
Inhibitors of the post-proline-cleaving serine proteases DPP8 and DPP9 trigger a lytic form of programmed cell death called pyroptosis by activating pro-caspase-1 without autoproteolysis. Val-boroPro (Talabostat, PT-100), a nonselective inhibitor of post-proline cleaving serine proteases, stimulates mammalian immune systems through an unknown mechanism of action. Despite this lack of mechanistic understanding, Val-boroPro has attracted substantial interest as a potential anticancer agent, reaching phase 3 trials in humans. Here we show that Val-boroPro stimulates the immune system by triggering a proinflammatory form of cell death in monocytes and macrophages known as pyroptosis. We demonstrate that the inhibition of two serine proteases, DPP8 and DPP9, activates the pro-protein form of caspase-1 independent of the inflammasome adaptor ASC. Activated pro-caspase-1 does not efficiently process itself or IL-1β but does cleave and activate gasdermin D to induce pyroptosis. Mice lacking caspase-1 do not show immune stimulation after treatment with Val-boroPro. Our data identify what is to our knowledge the first small molecule that induces pyroptosis and reveals a new checkpoint that controls the activation of the innate immune system.
科研通智能强力驱动
Strongly Powered by AbleSci AI